Showing results (451-460 of 585) with videos related to

Sort By:
Pageof 59
Oncology|March 21, 2019
Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency AblationAtsushi Hiraoka, Masashi Hirooka, Hironori Ochi, et al.
Journal of Gastroenterology|February 24, 2025
Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicenter studyTakashi Nishimura, Toshifumi Tada, Tomoyuki Akita, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 6, 2026
The Hepatic Steatosis Diagnostic Performance Using Attenuation Imaging With the Magnetic Resonance Imaging-Based Proton Density Fat Fraction as the Reference Standard: A Large, Prospective, Multicenter Cohort Study in JapanTakashi Nishimura, Hiroko Iijima, Yasuaki Suzuki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 30, 2019
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matchingToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Plos One|October 11, 2014
Circulating AIM as an indicator of liver damage and hepatocellular carcinoma in humansTomoko Yamazaki, Mayumi Mori, Satoko Arai, et al.
Euroasian Journal of Hepato-Gastroenterology|January 13, 2025
HeberNasvac: Development and Application in the Context of Chronic Hepatitis BJulio C Aguilar, Sheikh Mf Akbar, Mamun Al-Mahtab, et al.
Hepato-Gastroenterology|May 21, 2009
Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolizationAtsushi Hiraoka, Norio Horiike, Yoshimasa Yamashita, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|February 21, 2025
Characteristics of Adult Intussusception due to Malignancy in Japanese PatientsShogo Kitahata, Ayaka Nakamura, Yuka Kimura, et al.
Internal Medicine (Tokyo, Japan)|December 17, 2013
Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in JapanAkira Sato, Michio Sata, Kenji Ikeda, et al.
Cancer Medicine|May 26, 2019
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysisAtsushi Hiraoka, Takashi Kumada, Masanori Atsukawa, et al.
Pageof 59